EN DE
STOCK COMPARISON

Kronox Lab Sciences vs Linde: Fair Value & Quality

Both stocks run through our valuation models. Here is how Kronox Lab Sciences (KRONOX) and Linde (LIN) compare, as of Oct 3, 2026.

As of Oct 3, 2026, Fair Value Calculator sees Linde as the less overvalued of the two: Kronox Lab Sciences trades at ₹206 versus a fair value of ₹55.94 (−72.8%), while Linde trades at $479 versus $442 (−7.9%).
Kronox Lab Sciences
KRONOX.NSE · INR · Materials
−72.8%
upside to fair value
overvalued
Price₹206
Fair Value₹55.94
Quality71/100
Linde
LIN · USD · Materials
−7.9%
upside to fair value
fairly valued
Price$479
Fair Value$442
Quality69/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Kronox Lab SciencesLinde
Valuation
26.3×P/E (TTM)30.4×
n/aForward P/E (FY2027)26.4×
n/aMedian P/E at FY-end (10 FY, ex one-offs where documented)34.2×
7.22×P/S (TTM)6.15×
6.55×P/B5.70× · book value is mostly goodwill
21.4×EV/EBITDA16.9×
n/aPEG1.80×
−72.8%Fair value upside−7.9%
0.2%Dividend yield1.3%
₹0.50Dividend per share$6.20
Profitability
30.1%Operating margin28.1%
1.46×EBIT margin trend (5Y)1.84×
26.8%Return on equity18.4%
17.8%Return on assets7.2%
Growth
16.9%Revenue growth (YoY)9.3%
1.9%Avg. growth/yr (3Y)0.6%
n/aAvg. growth/yr (5Y)4.5%
+15.5%Value creation/yr+24.2%
Balance & size
282.7×Interest coverage (EBIT/interest)42.1×
0.01×Debt / equity0.54×
$79MMarket cap$218B
weakGrowth qualityhealthy
Linde, median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 7 of the years ex one-offs: 34.2.
Forward P/E: price divided by the analyst consensus for the first fiscal year that has not started yet. The current year carries special items from quarters already reported.

Linde leads: 6 to 7 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Kronox Lab Sciencesof which business quality 69 · market factors 70 Lindeof which business quality 66 · market factors 54
ProfitabilityMargins and returns on capital today
83
51
Quality GrowthAre margins and returns improving?
42
51
CashflowEarnings quality: real cash, not paper profit
69
64
Fin. StrengthBalance sheet, leverage, solvency risk
81
69
InvestmentDisciplined investing over empire-building
31
70
Low VolatilityCalm price path (market factor)
43
87
MomentumPrice trend over the last 3–12 months (market factor)
83
36
52W MomentumDistance to the 52-week high (market factor)
80
49
Net IssuanceShare count: buybacks or dilution?
84
95

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyKronox Lab SciencesPrice ₹206LindePrice $479
DCF Models−66.7%below the price₹68.51−54.8%below the price$217
Earnings-Based−76.1%below the price₹49.15−72.4%below the price$132
Dividend Discount−97.7%below the price₹4.65−75.7%below the price$116
Multiples−54.6%below the price₹93.36−50.0%below the price$240
Asset-Based−89.8%below the price₹20.97−88.4%below the price$55.59
Growth DCF−75.1%below the price₹51.27−66.6%below the price$160
Economic Profit−76.8%below the price₹47.74−67.5%below the price$156
Growth Earnings−50.8%below the price₹101−57.3%below the price$205
Minimum−97.7%below the price₹4.65−88.4%below the price$55.59
Maximum−50.8%below the price₹101−50.0%below the price$240
Median−75.6%below the price₹50.21−67.1%below the price$158
Geometric mean−80.2%below the price₹40.74−69.2%below the price$148

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Kronox Lab Sciences: 25 of 25 models see the stock below the current price.

Linde: 26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Kronox Lab Sciences
Price ₹206
Fair Value ₹55.94
Bear ₹41.30Bull ₹73.14
Linde
Price $479
Fair Value $442
Bear $247Bull $583

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Kronox Lab Sciences · Materials

Quality score71 · Top 25%
Fair value upside−72.8% · bottom 25%

Linde · Materials

Quality score69 · Top 25%
Fair value upside−7.9% · above median

Bottom line

As of Oct 3, 2026, Fair Value Calculator sees Linde as the less overvalued of the two: Kronox Lab Sciences trades at ₹206 versus a fair value of ₹55.94 (−72.8%), while Linde trades at $479 versus $442 (−7.9%).

Kronox Lab Sciences has the higher quality score (71/100).

Open Linde live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.